{
  "success": true,
  "pagesUsed": [
    7,
    8,
    9,
    11,
    12,
    13,
    19,
    20,
    21,
    24,
    25,
    26,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    41,
    42,
    43
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Axicabtagene ciloleucel",
        "type": {
          "id": "b1180c9b-7d1b-4cae-a89d-cdb3d4055c82",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "cba086e6-63b7-495e-92e8-dacb589e4fdb",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Autologous T cells transduced with retroviral vector containing anti-CD19 CD28/CD3ζ chimeric antigen receptor (KTE-C19)",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Standard of Care (SOC) Therapy",
        "type": {
          "id": "af229a8c-985f-41f1-821e-127bea94f6c6",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "c21af655-5507-4728-8ac6-f5434b2a54d3",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Second-line combination chemotherapy regimen (R-ICE, R-DHAP, R-ESHAP, or R-GDP) followed by HDT and ASCT for responders",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Fludarabine",
        "type": {
          "id": "21f81df3-4aab-4096-bce3-16ce34be83bd",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "a3dae038-7c09-422b-8b68-3ab2ecb8b481",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Conditioning chemotherapy for lymphodepletion prior to axicabtagene ciloleucel",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Cyclophosphamide",
        "type": {
          "id": "a6a38557-1d47-4748-9659-943cbb93124e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "cd26ded6-6922-422f-abb1-99c838cf0c2d",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Conditioning chemotherapy for lymphodepletion prior to axicabtagene ciloleucel",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Corticosteroids",
        "type": {
          "id": "2fd1ab45-bc06-4d4f-b37c-e91088b07a5e",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "5147c496-58fc-4528-b188-03a952de65bc",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Bridging therapy for subjects with high disease burden at screening",
        "administrationIds": [
          "admin_5"
        ]
      },
      {
        "id": "int_6",
        "name": "Mesna",
        "type": {
          "id": "3bd0509a-1df4-43a7-ada6-a59ca87f907f",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "de3b9103-ba9d-40d6-b965-a0cc5dd7a016",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Detoxifying agent used to prevent hemorrhagic cystitis induced by chemotherapy"
      },
      {
        "id": "int_7",
        "name": "G-CSF",
        "type": {
          "id": "6c879b8b-1f0c-4c9a-992a-fe01c3fb5d3d",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "42dd2b1c-e5d8-4579-a9fe-f42c30aab590",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Growth factor support for leukapheresis and prevention of chemotherapy delays/infection"
      },
      {
        "id": "int_8",
        "name": "Tocilizumab",
        "type": {
          "id": "f15900e8-089a-4ce2-8104-9301f7a0140e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "33f001cb-f4a9-4f41-bb49-707caf35c18e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Used for management of cytokine release syndrome (implied by hypersensitivity exclusion)"
      },
      {
        "id": "int_9",
        "name": "Systemic immunostimulatory agents",
        "type": {
          "id": "af07fd2a-0d5e-471d-b806-f4ea8ba0700a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "0efa5dd2-d3cc-40fb-b252-922ea0772fe4",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 6 weeks or 5 half-lives prior to first dose (e.g., interferon, IL-2)"
      },
      {
        "id": "int_10",
        "name": "Live, attenuated vaccine",
        "type": {
          "id": "b29b827f-06f6-46f7-b0fd-b398c70e15d0",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "119cb140-0a64-4d64-bc35-5f65c902a427",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 6 weeks prior to initiation of study treatment"
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Axicabtagene ciloleucel",
        "administrableDoseForm": {
          "id": "385cb3f5-8fcd-4aef-84af-ded09ed353d3",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "53e1bb12-3f6b-4c4a-95e8-68cd39df9f1a",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "3198a5a7-3d58-4504-975e-d45fb2e4d85e",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Target dose 2 x 10^6 anti-CD19 CAR T cells/kg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Kite Pharma, Inc."
      },
      {
        "id": "prod_2",
        "name": "Fludarabine",
        "administrableDoseForm": {
          "id": "7b6a3a08-af5e-412e-9743-e08bb9b4caf1",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "0182d22c-f133-47fd-bf4f-074406ccefd1",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "8a116580-d3ba-4ed9-9b52-4d8b68389d57",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "30 mg/m2",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_3",
        "name": "Cyclophosphamide",
        "administrableDoseForm": {
          "id": "eb80052b-a5ed-420c-a9c9-3f1cc5a4276b",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "5ed2ec52-29fc-4b5e-9359-926564e81071",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "29c11a45-2e54-4fd8-b6a6-ef3dc4bad2b0",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "500 mg/m2",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_4",
        "name": "Rituximab",
        "administrableDoseForm": {
          "id": "84452fff-0647-4077-ab92-9d453859a48d",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "3c1a4f24-6bd8-4d51-9c24-975f165335af",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "6627b97c-5e05-43bc-8ac3-7b1c3a8516ad",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "375 mg/m2",
        "substanceIds": [
          "sub_4"
        ],
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Axicabtagene ciloleucel infusion",
        "instanceType": "Administration",
        "dose": "2 x 10^6 anti-CD19 CAR T cells/kg",
        "doseFrequency": "Single infusion",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Single dose on Treatment Day 0"
      },
      {
        "id": "admin_2",
        "name": "Conditioning Chemotherapy (Fludarabine)",
        "instanceType": "Administration",
        "dose": "30 mg/m2/day",
        "doseFrequency": "Once daily",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "3 days (Day -5 to Day -3)"
      },
      {
        "id": "admin_3",
        "name": "Conditioning Chemotherapy (Cyclophosphamide)",
        "instanceType": "Administration",
        "dose": "500 mg/m2/day",
        "doseFrequency": "Once daily",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "3 days (Day -5 to Day -3)"
      },
      {
        "id": "admin_4",
        "name": "Bridging Therapy (Dexamethasone)",
        "instanceType": "Administration",
        "dose": "20 to 40 mg",
        "doseFrequency": "Daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "1 to 4 days"
      },
      {
        "id": "admin_5",
        "name": "R-ICE Regimen",
        "instanceType": "Administration",
        "dose": "Rituximab 375mg/m2; Ifosfamide 5g/m2; Carboplatin AUC 5; Etoposide 100mg/m2",
        "doseFrequency": "Every 2-3 weeks",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "2 or 3 cycles"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Axicabtagene ciloleucel",
        "instanceType": "Substance",
        "description": "Autologous anti-CD19 CAR T cells"
      },
      {
        "id": "sub_2",
        "name": "Fludarabine phosphate",
        "instanceType": "Substance",
        "description": "Synthetic purine nucleoside antimetabolite"
      },
      {
        "id": "sub_3",
        "name": "Cyclophosphamide",
        "instanceType": "Substance",
        "description": "Nitrogen mustard-derivative alkylating agent"
      },
      {
        "id": "sub_4",
        "name": "Sodium-2-mercaptoethane sulfonate",
        "instanceType": "Substance",
        "description": "Active ingredient in Mesna"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 10,
      "productCount": 4,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Axicabtagene ciloleucel",
        "role": "Investigational Product",
        "description": "Autologous T cells transduced with retroviral vector containing anti-CD19 CD28/CD3ζ chimeric antigen receptor (KTE-C19)"
      },
      {
        "name": "Standard of Care (SOC) Therapy",
        "role": "Comparator",
        "description": "Second-line combination chemotherapy regimen (R-ICE, R-DHAP, R-ESHAP, or R-GDP) followed by HDT and ASCT for responders"
      },
      {
        "name": "Fludarabine",
        "role": "Investigational Product",
        "description": "Conditioning chemotherapy for lymphodepletion prior to axicabtagene ciloleucel"
      },
      {
        "name": "Cyclophosphamide",
        "role": "Investigational Product",
        "description": "Conditioning chemotherapy for lymphodepletion prior to axicabtagene ciloleucel"
      },
      {
        "name": "Corticosteroids",
        "role": "Background Therapy",
        "description": "Bridging therapy for subjects with high disease burden at screening"
      },
      {
        "name": "Mesna",
        "role": "Concomitant Medication",
        "description": "Detoxifying agent used to prevent hemorrhagic cystitis induced by chemotherapy"
      },
      {
        "name": "G-CSF",
        "role": "Concomitant Medication",
        "description": "Growth factor support for leukapheresis and prevention of chemotherapy delays/infection"
      },
      {
        "name": "Tocilizumab",
        "role": "Concomitant Medication",
        "description": "Used for management of cytokine release syndrome (implied by hypersensitivity exclusion)"
      },
      {
        "name": "Systemic immunostimulatory agents",
        "role": "Concomitant Medication",
        "description": "Prohibited within 6 weeks or 5 half-lives prior to first dose (e.g., interferon, IL-2)"
      },
      {
        "name": "Live, attenuated vaccine",
        "role": "Concomitant Medication",
        "description": "Prohibited within 6 weeks prior to initiation of study treatment"
      }
    ],
    "products": [
      {
        "name": "Axicabtagene ciloleucel",
        "doseForm": "Injection",
        "strength": "Target dose 2 x 10^6 anti-CD19 CAR T cells/kg",
        "manufacturer": "Kite Pharma, Inc."
      },
      {
        "name": "Fludarabine",
        "doseForm": "Injection",
        "strength": "30 mg/m2",
        "manufacturer": "Not specified"
      },
      {
        "name": "Cyclophosphamide",
        "doseForm": "Injection",
        "strength": "500 mg/m2",
        "manufacturer": "Not specified"
      },
      {
        "name": "Rituximab",
        "doseForm": "Injection",
        "strength": "375 mg/m2",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Axicabtagene ciloleucel",
        "description": "Autologous anti-CD19 CAR T cells"
      },
      {
        "name": "Fludarabine phosphate",
        "description": "Synthetic purine nucleoside antimetabolite"
      },
      {
        "name": "Cyclophosphamide",
        "description": "Nitrogen mustard-derivative alkylating agent"
      },
      {
        "name": "Sodium-2-mercaptoethane sulfonate",
        "description": "Active ingredient in Mesna"
      }
    ],
    "administrations": [
      {
        "name": "Axicabtagene ciloleucel infusion",
        "dose": "2 x 10^6 anti-CD19 CAR T cells/kg",
        "frequency": "Single infusion",
        "route": "Intravenous",
        "duration": "Single dose on Treatment Day 0"
      },
      {
        "name": "Conditioning Chemotherapy (Fludarabine)",
        "dose": "30 mg/m2/day",
        "frequency": "Once daily",
        "route": "Intravenous",
        "duration": "3 days (Day -5 to Day -3)"
      },
      {
        "name": "Conditioning Chemotherapy (Cyclophosphamide)",
        "dose": "500 mg/m2/day",
        "frequency": "Once daily",
        "route": "Intravenous",
        "duration": "3 days (Day -5 to Day -3)"
      },
      {
        "name": "Bridging Therapy (Dexamethasone)",
        "dose": "20 to 40 mg",
        "frequency": "Daily",
        "route": "Oral or Intravenous",
        "duration": "1 to 4 days"
      },
      {
        "name": "R-ICE Regimen",
        "dose": "Rituximab 375mg/m2; Ifosfamide 5g/m2; Carboplatin AUC 5; Etoposide 100mg/m2",
        "frequency": "Every 2-3 weeks",
        "route": "Intravenous",
        "duration": "2 or 3 cycles"
      }
    ],
    "devices": []
  }
}